Publisher
Springer Nature Singapore
Reference95 articles.
1. Meyer UA. Pharmacogenetics–five decades of therapeutic lessons from genetic diversity. Nat Rev Genet. 2004;5(9):669.
2. Relling MV, McDonagh EM, Chang T, Caudle KE, McLeod HL, Haidar CE, et al. Clinical Pharmacogenetics Implementation Consortium (CPIC) guidelines for rasburicase therapy in the context of G6PD deficiency genotype. Clin Pharmacol Ther. 2014;96(2):169–74.
3. Garrod AE. Inborn errors of metabolism: H. London: Frowde and Hodder & Stoughton; 1909.
4. Gonzalez FJ, Skoda RC, Kimura S, Umeno M, Zanger UM, Nebert DW, et al. Characterization of the common genetic defect in humans deficient in debrisoquine metabolism. Nature. 1988;331(6155):442–6.
5. Food, Drug Administration HHS. International conference on harmonisation; guidance on E15 pharmacogenomics definitions and sample coding; availability. Notice. Federal register. 2008;73(68):19074–6.